DCAF15 and ovarian carcinoma: One of the candidate TICTOC genes, DCAF15, was found frequently amplified in ovarian cancer, and DCAF15 inhibition led to enhanced NK cell-mediated cytotoxicity, suggesting CNAs as alternative immunotherapy targets in ovarian cancers that are resistant to traditional ICI.2